Production of vaccine against cervical cancer to be boosted: Adar Poonawalla
NEW DELHI: A day after the first indigenously developed Human Papillomavirus vaccine against cervical cancer was launched, Serum Institute of...
NEW DELHI: A day after the first indigenously developed Human Papillomavirus vaccine against cervical cancer was launched, Serum Institute of...
PUNE: Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the...
SINGAPORE: Multilateral organisations like the UN and the WTO should take it upon themselves to harmonise the certification of vaccines...
NEW DELHI: Children aged 12 to 17 years can now get the Serum Institute's coronavirus vaccine Covovax at private centres...
NEW DELHI: India’s drug regulator has granted restricted emergency use authorisation to Serum Institute’s COVID-19 vaccine Covovax for the 12-17...
NEW DELHI: An expert panel of India's Central Drug Authority on Tuesday recommended granting permission to Serum Institute of India...
NEW DELHI: The WHO is urgently trying to work with AstraZeneca, Serum Institute of India (SII) as well as the...
NEW DELHI: In the first of its kind study since the launch of the AstraZeneca's Covishield and Bharat Biotech's Covaxin...
LONDON: The Serum Institute of India (SII) will invest GBP 240 million in the UK to expand its vaccine business...
MUMBAI: Serum Institute of India (SII) CEO Adar Poonawalla has said he will return to India from London in a...